Retinal Emboli Linked to Cardiac Risk Factors, Kidney Disease

Share this content:
Retinal Emboli Linked to Cardiac Risk Factors, Kidney Disease
Retinal Emboli Linked to Cardiac Risk Factors, Kidney Disease

THURSDAY, Aug. 31, 2017 (HealthDay News) -- Retinal emboli are associated with conventional cardiovascular risk factors, stroke, and chronic kidney disease, according to a study published online Aug. 24 in JAMA Ophthalmology.

Ning Cheung, M.D., from the Singapore Eye Research Institute, and colleagues examined the prevalence of and risk factors for retinal emboli in a large contemporary multiethnic Asian population. Data were included for 10,033 Chinese, Malay, and Indian adults aged 40 to 80 years. Retinal emboli were ascertained from retinal photographs obtained from both eyes of all participants.

The researchers found that 99.5 percent of the participants had gradable retinal photographs. Overall, 0.9 percent of participants had retinal emboli; the overall person-specific, age-standardized prevalence of retinal emboli was 0.75 percent, with prevalence varying in the cohorts (0.98, 0.73, and 0.44 percent among Indian, Chinese, and Malay cohorts, respectively). Older age (odds ratio, 1.22 per five-year increase), Indian ethnicity (odds ratio, 3.58 compared with Malay ethnicity), hypertension (odds ratio, 1.95), chronic kidney disease (odds ratio, 2.05), creatinine level (odds ratio, 1.13 per standard deviation increase), glomerular filtration rate (odds ratio, 0.67 per standard deviation increase), and history of stroke (odds ratio, 3.45) were associated with prevalent retinal emboli in multivariable-adjusted analysis.

"If these data are confirmed in longitudinal studies, they would suggest that persons with retinal emboli may require both general cardiovascular and renal assessment," the authors write.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »